Numerous mutations in signaling genes, such as CBL, JAK2, NRAS, KRAS, CSF3R, and others involving the spliceosome complex have been identified in MDS/MPN disorders, therefore supporting the notion of MDS/MPN as heterogeneous clonal disorders. This evidence concerns the gene JAK2 and myeloproliferative disorder.